---
figid: PMC7937683__41418_2020_628_Fig8_HTML
figlink: pmc/articles/PMC7937683/figure/Fig8/
number: F8
caption: a Dsg2 functions as a tumor suppressor through binding between the Dsg2 IL
  domain and cSrc SH2 domain. The EGFR-targeted therapy suppresses EGFR signaling
  pathway. b The loss of Dsg2 in GBC activates cSrc and promotes EGFR internalization,
  which induces resistance to EGFR-targeted therapy. c Combination therapy targeting
  both cSrc and EGFR is a promising therapeutic strategy for GBC patients with Dsg2
  loss.
pmcid: PMC7937683
papertitle: Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance
  to EGFR-targeted therapy through Src kinase activation.
reftext: Sang-Hyun Lee, et al. Cell Death Differ. 2021 Mar;28(3):968-984.
pmc_ranked_result_index: '52514'
pathway_score: 0.8727424
filename: 41418_2020_628_Fig8_HTML.jpg
figtitle: Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance
  to EGFR-targeted therapy through Src kinase activation
year: '2021'
organisms:
- Mus musculus
- Armoracia rusticana
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7937683__41418_2020_628_Fig8_HTML.html
  '@type': Dataset
  description: a Dsg2 functions as a tumor suppressor through binding between the
    Dsg2 IL domain and cSrc SH2 domain. The EGFR-targeted therapy suppresses EGFR
    signaling pathway. b The loss of Dsg2 in GBC activates cSrc and promotes EGFR
    internalization, which induces resistance to EGFR-targeted therapy. c Combination
    therapy targeting both cSrc and EGFR is a promising therapeutic strategy for GBC
    patients with Dsg2 loss.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - DSG2
  - EGFR
  - TYR
  - MAPK3
  - MAPK1
  - Dasatinib
genes:
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: Dsg2
  symbol: DSG2
  source: hgnc_symbol
  hgnc_symbol: DSG2
  entrez: '1829'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Туг
  symbol: TYR
  source: hgnc_symbol
  hgnc_symbol: TYR
  entrez: '7299'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Dsg2
  symbol: DSG2
  source: hgnc_symbol
  hgnc_symbol: DSG2
  entrez: '1829'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Dsg2
  symbol: DSG2
  source: hgnc_symbol
  hgnc_symbol: DSG2
  entrez: '1829'
chemicals:
- word: Dasatinib
  source: MESH
  identifier: C488369
diseases: []
figid_alias: PMC7937683__F8
redirect_from: /figures/PMC7937683__F8
figtype: Figure
---
